TOKYO WOMEN'S MEDICAL UNIVERSITY
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Private
- Established
- 1900-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
6
Active:0
Completed:4
Trial Phases
3 Phases
Phase 1:1
Phase 4:1
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
4 (66.7%)Phase 1
1 (16.7%)Phase 4
1 (16.7%)Simultaneous Bilateral Radiofrequency Thalamotomy for Medication-Refractory Essential Tremor
Not Applicable
Recruiting
- Conditions
- Essential Tremor
- First Posted Date
- 2025-07-15
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Tokyo Women's Medical University
- Target Recruit Count
- 5
- Registration Number
- NCT07066358
- Locations
- π―π΅
Tokyo Women's Medical University, Department of Neurosurgery, Shinjuku-Ku, Tokyo, Japan
Conversion From Total Intravenous Anesthesia Technique to Desflurane Anesthesia for Long Duration Neurosurgery
- First Posted Date
- 2013-11-15
- Last Posted Date
- 2013-11-15
- Lead Sponsor
- Tokyo Women's Medical University
- Target Recruit Count
- 60
- Registration Number
- NCT01985854
- Locations
- π―π΅
Tokyo Women's Medical University Hospital, Tokyo, Japan
Bifidobacterium Supplementation for Very Low Birth Weight Infants
Not Applicable
Completed
- Conditions
- Preterm Infants
- First Posted Date
- 2011-06-17
- Last Posted Date
- 2012-03-30
- Lead Sponsor
- Tokyo Women's Medical University
- Target Recruit Count
- 246
- Registration Number
- NCT01375309
- Locations
- π―π΅
Tokyo Women's Medical Unversity, Shinjuku, Tokyo, Japan
Early Administration of Bifidobacterium to Very Low Birth Weight Infants
Not Applicable
Completed
- Conditions
- Preterm Infants
- First Posted Date
- 2011-04-06
- Last Posted Date
- 2011-04-06
- Lead Sponsor
- Tokyo Women's Medical University
- Target Recruit Count
- 36
- Registration Number
- NCT01330095
- Locations
- π―π΅
Tokyo Women's Medical Unversity, Shinjuku, Tokyo, Japan
Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases
Phase 1
Completed
- Conditions
- Kidney CancerMetastatic Cancer
- First Posted Date
- 2008-01-09
- Last Posted Date
- 2013-07-10
- Lead Sponsor
- Tokyo Women's Medical University
- Target Recruit Count
- 20
- Registration Number
- NCT00588913
- Locations
- π―π΅
Kyoto University Hospital, Kyoto, Japan
π―π΅Tokyo Women's Medical University, Tokyo, Japan
- Prev
- 1
- 2
- Next
News
No news found